independent pathway associated with the stimulation of interferons. TLR3 utilizes TRIF to mediate its signaling [3] .
A number of accessory molecules have been shown to assist microbial recognition by TLRs. For example, LPS is extracted from the bacterial membrane by the LPS-binding protein (LBP), after which it is transferred to CD14. Subsequent transfer from CD14 to an additional accessory molecule MD-2 then allows TLR4-mediated LPS recognition [4, 5] . HMGB1 can also mediate LPS transfer to CD14 to initiate a TLR4-mediated pro-inflammatory response [6] . For TLR3, the structure of the extracellular domain of TLR3 was revealed by crystallography studies as a large horseshoe-shape [7] . It has been shown that CD14, scavenger receptor class-A and clathrin-mediated endocytic pathways participate in cellular uptake of extracellular dsRNA [8] [9] [10] . However, how endocytosed dsRNA is presented to TLR3 in intracellular compartments is still poorly understood.
In a recent paper in Cell Research [11] , the authors found that an RNAbinding protein Mex3B is involved in this process. Mex3B is associated with TLR3 in the endosomes and promotes the dsRNA binding and proteolytic processing of TLR3 through its own RNAbinding ability, and consequently helps TLR3 activate downstream signals.
Initially, from a cDNA array containing 352 expression clones of ubiquitinrelated proteins, the authors identified an RNA-binding protein Mex3B as a positive regulator of TLR3-mediated signaling using IFN-β promoter reporter assay in 293-TLR3 stable cell line. By in vitro overexpression and knockdown experiments in 293-TLR3 stable cells, they showed that Mex3B was involved in poly (I:C)-induced, TLR3-mediated signaling, but not SeV-induced signaling. To further confirm their observation, they generated Mex3B-deficient mice. Consistently, poly(I:C)-induced IRF3 and IκBα phosphorylation and IFN-β production were impaired in Mex3B -/-MEFs, BMDMs or BMDCs, while SeV-, VSV-and EMCV-induced signalings were not affected. In vivo, they also observed less IFN-β and TNFα production in the serum and less mortality in Mex3B
-/-mice challenged with poly(I:C). These data suggest that Mex3B is specifically required and important for TLR3-mediated but not RLR-mediated signaling.
The authors then investigated how Mex3B facilitates TLR3 signaling. They constructed a series of truncation and point mutants of Mex3B and TLR3 to determine the binding and functional domains. Through co-IP experiments and IFN-β promoter reporter assay with these truncations, the authors found that two RNA-binding KH domains in Mex3B and proteolytic cleavage of TLR3 are indispensable for Mex3B to potentiate TLR3-mediated signaling. The authors also demonstrated that Mex3B and TLR3-mediated poly (I:C)-induced signaling requires endosomal acidification. By immunofluorescence confocal microscopy, they found that Mex3B and TLR3 colocalized with the endosome marker EEA1, though overexpressing both Mex3B and TLR3 in 293T cells may not be a perfect reflection of an endogenous situation with physiologic protein levels. Proteinase K protection assay also suggests that npg Mex3B and TLR3 are in the lumen of the endosomes.
The author further analyzed whether Mex3B physically interacts with TLR3 and the mechanism whereby Mex3B participates in TLR3 signaling. By endogenous co-IP experiments in cells treated with poly (I:C), the authors found that Mex3B is associated with TLR3, and bound to TRIF in a poly (I:C) signaling-dependent manner. Further, to test whether Mex3B affects the cleavage of TLR3, the authors overexpressed or knocked down Mex3B in 293 cells transfected with TLR3, and found that Mex3B promotes TLR3 processing. Lastly, the authors tested whether the RNA-binding protein Mex3B modulated the dsRNA-binding ability of TLR3. By performing biotin-labeled poly (I:C) pull-down experiments, they found that full-length Mex3B bound to poly (I:C) directly and facilitated the binding of TLR3 to poly (I:C), while dominantnegative form of Mex3B, which lacks RNA-binding activity, could not bind to poly (I:C) and inhibited the binding of TLR3 to poly (I:C 
